Method for determination of glucose concentration

• US 5,168,046 A
• Filed: 07/05/1990
• Issued: 12/01/1992
• Est. Priority Date: 07/13/1989
• Status: Expired due to Term

• Current Assignee: Kyoto Daiichi Kagaku Company Limited
• Original Assignee: Kyoto Daiichi Kagaku Company Limited
• Inventors: Hirose, Kazunori, Hamamoto, Katsumi
• Primary Examiner(s): Naff, David M.
• Assistant Examiner(s): REARDON, TIMOTHY
• Application Number:
  US07/548,367
• Time in Patent Office: 880 Days
• Field of Search: 435/14, 435/25, 436/95
• US Class Current: 435/14
• CPC Class Codes: C12Q 1/006 for glucose
• CPC Class Codes: C12Q 1/54 involving glucose or galactose
• CPC Class Codes: Y10T 436/144444 Glucose

Abstract

There is provided a method for the determination of a glucose concentration in a whole blood utilizing a biosensor. A correction of the measured glucose concentration for dilution error introduced by the solid component of blood cells is calculated based on the change in glucose concentration measured before and after significant glucose has diffused from blood cells into the buffer used to dilute the sample. Thus, the need to centrifuge blood samples to obtain a cell-free serum sample for glucose determination is eliminated.

Claims

1. A method for the in vitro measurement of the concentration of glucose in a whole blood sample, which comprises:

A) obtaining a calibration curve relating (a) a conversion factor, defined as the ratio of the measured glucose concentration in a whole blood sample to the measured glucose concentration of the serum from said whole blood sample to (b) the proportion of the whole blood volume that consists of the serum fraction;

B) creating a calibration curve relating (a) the ratio of glucose concentration in said whole blood sample measured before glucose has diffused out of the cells into a solution used to dilute said whole blood sample to the glucose concentration measured in said whole blood sample after glucose has diffused out of the cells into said solution to (b) the proportion of the whole blood volume that consists of the serum fraction;

C) diluting a whole blood sample in which the glucose concentration is to be determined in a solution suitable for measuring glucose concentration;

D) obtaining a first value (Cy) of the concentration of glucose in the sample solution of step (C) before the glucose contained within the cells has diffused out of the cells into the solution used to dilute the sample;

E) obtaining a second value (Cx) of the concentration of glucose in the sample solution of step (C) after the glucose contained within the cells has diffused out of the cells into the solution used to dilute the sample;

F) obtaining the ratio of Cx/Cy from the values obtained in steps (D) and (E);

G) estimating the proportion of the whole blood volume of said whole blood sample of step (C) which consists of the serum fraction (X) by reference to the calibration curve obtained in step (B);

H) obtaining the value for the conversion factor at the value of X determined in step (G) by reference to the calibration curve obtained in step (A); and

I) determining the concentration of glucose in the whole blood sample of step (C) by multiplying the value of Cx obtained in step (E) by the value of the conversion factor obtained in step (H).

2. A method for the in vitro measurement of the concentration of glucose in a whole blood sample, which comprises:

A) obtaining whole blood sample and separating it into the serum and cellular fractions;

B) mixing the separated fractions of step (A) in varying proportions;

C) diluting the samples obtained from step B) in a vessel with a solution suitable for measuring the glucose concentration in the diluted sample;

D) obtaining a first value of the concentration of glucose in each of said diluted samples before the glucose contained within the cells has diffused out of the cells into the solution used to dilute the sample (Cy);

E) obtaining a second value of the concentration of glucose in each of said diluted samples after the glucose contained within the cells has diffused out of the cells into the solution used to dilute the sample (Cs);

F) creating a calibration curve relating the proportion of the whole blood sample which comprises the serum fraction (X) to the ratio of the value of step (E) to the value of step (D) (Cx/Cy);

G) creating a calibration curve relating the conversion factor (Co/Cx), said conversion factor being the ratio of Cx when X is 100% (Co) to the Cx obtained at variable values of X to the proportion of the whole blood volume which consists of the volume of the cellular fraction (1-X);

H) obtaining a whole blood sample in which the glucose concentration is to be determined;

I) diluting said whole blood sample in a solution suitable for the measurement of glucose concentration in said diluted sample;

J) obtaining a first value of the concentration of glucose in the sample solution obtained in step (I) before the glucose contained within the cells has diffused out of the cells into the solution used to dilute the sample;

K) obtaining a second value of the concentration of glucose in the sample solution obtained in step (I) after the glucose contained within the cells has diffused out of the cells into the solution used to dilute the sample;

L) obtaining the ratio of Cx/Cy from the values obtained in steps J) and K);

M) estimating the proportion of the whole blood volume in the whole blood sample of step (H) which consists of the serum fraction (X) by reference to the calibration curve obtained in step F);

N) obtaining the value of the proportion of whole blood volume in the whole blood sample of step (H) which consists of the volume of the cellular fraction by the ration 1-X;

O) obtaining the value for the conversion factor at the value of 1-X determined in step (N) by reference to the calibration curve obtained in step (G); and

P) determining the concentration of glucose in the whole blood sample of step (H) by multiplying the value of Cx obtained in step (K) by the value of the conversion factor obtained in step (O).

3. The method of claim 2, wherein the values in steps E and K are obtained by:

EK1) diluting a standard solution of known glucose concentration in said solution suitable for measuring the glucose concentration;

EK2) measuring the value of the current output of an electrode, after the current output has reached steady state, as a function of glucose concentration in said diluted standard solution to obtain a calibration curve relating electrode current and glucose concentration; and

EK3) measuring the glucose concentration in the blood samples by measuring the output current of the electrode and referring to the calibration curve obtained in step EK2;

and wherein the measurements made in steps D and J are obtained by;

DJ1) diluting a standard solution of known glucose concentration in said solution suitable for measuring glucose concentration;

DJ2) measuring the maximum value of the first derivative with respect to time of the output current of the electrode as a function of glucose concentration in said diluted standard solution to obtain a calibration curve relating said maximum value of the first derivative and glucose concentration; and

DJ3) measuring the glucose concentration in the blood samples by measuring the maximum value of said first derivative and referring to the calibration curve in step (DJ2).

4. The method of claim 3, wherein the calibration curve in step (DJ2) is made and the value of Cy is measured using teh maximum value of the second, or higher derivative with respect to time of the output current of the electrode

5. The method of claim 3, wherein the electrode is an oxygen electrode or a hydrogen peroxide electrode or a field effect transistor.

6. The method of claim 5, wherein said electrode is operatively linked so as to measure the rate of a glucose oxidase enzymatic reaction.

7. The method of claim 6, wherein said glucose oxidase enzyme is immobilized on a membrane surface.

8. A method for the measurement of the concentration of glucose in a whole blood sample, by means of a hydrogen peroxide electrode (HPE) the output of which is a function of the progress of a glucose oxidase enzymatic reaction occurring in a vessel, which comprises:

A) diluting a standard solution of defined glucose concentration in a buffer in a reaction vessel containing glucose oxidase and a HPE, and obtaining a calibration curve relating the current of the HPE, measured when the rate of hydrogen peroxide production has reached a steady state, to the concentration of glucose;

B) diluting a standard solution of defined glucose concentration in said buffer in said reaction vessel, and obtaining a calibration curve relating the maximum value of the first derivative with respect to time of the current of the HPE to the concentration of glucose;

C) obtaining a whole blood sample and separating it into the serum and cellular fractions;

D) mixing the separated fractions of step (C) in varying proportions to form a series of reconstituted whole blood samples;

E) diluting the samples obtained from step (D) in a buffer suitable for measuring the glucose concentration in the diluted sample;

F) obtaining a first reading in each of the diluted samples of step (E), of the current generated by the HPE, after the rate of hydrogen peroxide production has reached a steady state, then converting said first reading into a first measurement of the glucose concentration in said diluted samples of step (E) by reference to the calibration curve obtained in step (A), the value of said measurement being called Cx;

(G) obtaining a second reading in each of the diluted samples of step (E), of the maximum value of the first derivative with respect to time, of the current generated by the HPE, then converting said second reading into a second measurement of the glucose concentration in said diluted samples of step (E) by reference to the calibration curve obtained in step (B), the value of said measurement being called Cy;

H) creating a calibration curve relating the proportion of the whole blood sample which comprises the serum fraction (X) to the ratio of the measurement of step (F) to the measurement of step (G) (Cx/Cy);

I) creating a calibration curve relating the conversion factor (Co/Cx), said conversion factor being the ratio of Cx when X is 100% (Co) to the Cx obtained at variable values of X, to the proportion of the whole blood volume which consists of the volume of the cellular fraction (1-X);

J) obtaining a whole blood sample in which the glucose concentration is to be determined and diluting said whole blood sample with said buffer in said reaction vessel;

K) obtaining a first reading in said whole blood sample of step (J), of the current generated by the HPE, after the rate of hydrogen peroxide production has reached a steady state, then converting said first reading into a first measurement of the glucose concentration in said whole blood sample by reference to the calibration curve obtained in step (A), the value of said measurement being called Cx;

L) obtaining a second reading in said whole blood sample of step (J), of the maximum value of the first derivative with respect to time, of the current generated by the HPE, then converting said second reading into a second measurement of the glucose concentration in said whole blood sample by reference to the calibration curve obtained in step (B), the value of said measurement being called Cy;

M) estimating the fraction of the whole blood volume in the whole blood sample of step (J) that consists of the serum volume (X) by reference to the calibration curve obtained in step (H);

N) estimating the fraction of the whole blood volume in the whole blood sample of step (J) that consists of the blood cell volume by the relationship, 1-(X);

O) determining a conversion factor (Co/Cx) by reference to the calibration curve obtained in step (I); and

P) multiplying said first measurement of step (K), Cx, by the conversion factor obtained in step (O) to obtain the value of the true glucose concentration in the whole blood of step (J), Co.

9. The method of claim 8, wherein the calibration curve in step (B) is made and the value of Cy is measured using the maximum value of the second, or higher, derivative with respect to time of the current of the HPE.

10. The method of claim 8, wherein the glucose oxidase is immobilized as part of the hydrogen peroxide electrode.

11. The method of claim 8, wherein the HPE is replaced by an oxygen electrode or field effect transistor as the sensor.